BCM
SRTA

BlueCrest Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

BlueCrest Capital Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-287,273
Closed -$2.54M – 277
2021
Q4 		$2.54M Buy
+287,273
New +$2.73M 0.08% 170

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
HVCM
HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return

BlueCrest Capital Management's SRTA Position: Q1 2022 in Review

BlueCrest Capital Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2022, closing a stake of 287,273 shares — an estimated $2.54M sold.

BlueCrest Capital Management first reported a position in SRTA in Q4 2021 and held it in 1 quarter. The position peaked at $2.54M in Q4 2021. 78 funds tracked by Wall St. Rank hold SRTA as of Q1 2022.

  • BlueCrest Capital Management reported no remaining Strata Critical Medical Inc position as of Q1 2022 after selling out during the quarter.
  • BlueCrest Capital Management sold 287,273 Strata Critical Medical Inc shares in Q1 2022, an estimated $2.54M.
  • BlueCrest Capital Management first reported a position in Strata Critical Medical Inc in Q4 2021 and held it in 1 quarter.
  • BlueCrest Capital Management's Strata Critical Medical Inc position peaked at $2.54M in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2022.

Based on BlueCrest Capital Management's 13F filing for Q1 2022, filed 16 May 2022.